Generate a tailored SOP for Dr. Richard Markham. Improve your application with a focused, well-structured draft.
Richard Markham studies cellular molecular processes surrounding host-pathogen interactions and develops immunological approaches to combat infectious diseases. His recent efforts have focused on developing a novel vaccine platform that has demonstrated the ability to elicit profoundly elevated and sustained humoral and cell-mediated immune responses, with malaria as the initial target. This target was chosen due to its public health significance and the available infrastructure at the Johns Hopkins Bloomberg School of Public Health's Malaria Research Institute. His work has involved creating vaccines capable of eliciting protective immune responses and exploring the basis for extended immunological memory. Additionally, he investigates the application of candidate vaccine platforms in cancer immunotherapy and employs toxin-fused camelid-derived antibodies for treating viral infections such as HIV.
Department of Pathology - PhD in Pathobiology. GRE is not required.